XML 43 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Michael Raab [Member]    
Trading Arrangements, by Individual    
Name Michael Raab  
Title President and Chief Executive Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 13, 2023  
Arrangement Duration 390 days  
Aggregate Available 331,300 331,300
Elizabeth Grammer [Member]    
Trading Arrangements, by Individual    
Name Elizabeth Grammer  
Title Chief Legal Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 20, 2023  
Arrangement Duration 209 days  
Aggregate Available 131,000 131,000
Robert Blanks [Member]    
Trading Arrangements, by Individual    
Name Robert Blanks  
Title Chief Regulatory Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 21, 2023  
Arrangement Duration 183 days  
Aggregate Available 48,000 48,000
Laura Williams [Member]    
Trading Arrangements, by Individual    
Name Laura Williams  
Title Chief Medical Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 27, 2023  
Arrangement Duration 91 days  
Aggregate Available 79,949 79,949
Officer Trading Arrangement [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
During the three months ended December 31, 2023, our Section 16 officers and directors adopted or terminated contracts, instructions or written plans for the purchase or sale of our securities as noted below:
Name and Title of Director or Officer
ActionDateTrading Arrangement
Total Shares Available to be Sold
Expiration Date
Rule 10b5-1*Non-Rule 10b5-1**
Michael Raab, President and Chief Executive Officer
AdoptionDecember 13, 2023
X
331,300 January 6, 2025
Elizabeth Grammer, Chief Legal Officer
AdoptionDecember 20, 2023
X
131,000 July 16, 2024
Robert Blanks, Chief Regulatory Officer
AdoptionDecember 21, 2023
X
48,000 June 21, 2024
Laura Williams, Chief Medical Officer
AdoptionDecember 27, 2023X79,949 March 27, 2024
*Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)
** Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)